- Home
- KIRK vs SABS Comparison
KIRK vs SABS Comparison
Compare KIRK & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- SABS
- Stock Information
- Founded
- KIRK 1966
- SABS 2014
- Country
- KIRK United States
- SABS United States
- Employees
- KIRK N/A
- SABS N/A
- Industry
- KIRK Diversified Commercial Services
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- SABS Health Care
- Exchange
- KIRK Nasdaq
- SABS Nasdaq
- Market Cap
- KIRK 20.2M
- SABS 19.0M
- IPO Year
- KIRK 2002
- SABS N/A
- Fundamental
- Price
- KIRK $1.46
- SABS $1.82
- Analyst Decision
- KIRK Buy
- SABS Strong Buy
- Analyst Count
- KIRK 2
- SABS 5
- Target Price
- KIRK $4.50
- SABS $12.40
- AVG Volume (30 Days)
- KIRK 203.3K
- SABS 246.2K
- Earning Date
- KIRK 03-20-2025
- SABS 03-28-2025
- Dividend Yield
- KIRK N/A
- SABS N/A
- EPS Growth
- KIRK N/A
- SABS N/A
- EPS
- KIRK N/A
- SABS N/A
- Revenue
- KIRK $458,411,000.00
- SABS $1,512,723.00
- Revenue This Year
- KIRK N/A
- SABS N/A
- Revenue Next Year
- KIRK $0.37
- SABS N/A
- P/E Ratio
- KIRK N/A
- SABS N/A
- Revenue Growth
- KIRK N/A
- SABS N/A
- 52 Week Low
- KIRK $1.39
- SABS $1.60
- 52 Week High
- KIRK $3.00
- SABS $6.30
- Technical
- Relative Strength Index (RSI)
- KIRK 37.18
- SABS 36.28
- Support Level
- KIRK $1.51
- SABS $2.00
- Resistance Level
- KIRK $1.58
- SABS $2.15
- Average True Range (ATR)
- KIRK 0.07
- SABS 0.20
- MACD
- KIRK -0.00
- SABS 0.03
- Stochastic Oscillator
- KIRK 0.00
- SABS 30.99
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.